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fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one; DTG, 1,3-di-o-tolylguanidine; 
HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; HIF1α, hypoxia-inducible factor 1 
alpha; MEM, Minimal Essential Media; MTT, 3-[4,5 dimethylthaizol-2-y]-2,5 
diphenyltetrazolium bromide; -NCS, isothiocyanate substituent; PGRMC1, progesterone 
receptor membrane component 1; PhNCS, phenyl isothiocyanate; ROS, reactive oxygen species; 
RT, room temperature; SN79, 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-
yl)butyl)benzo[d]oxazol-2(3H)-one; Tris, tris(hydroxymethyl)aminomethane; VEGF, vascular 
endothelial growth factor. 
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Sigma-2 receptors, recently identified as TMEM97, have been implicated in cancer and 
neurodegenerative disease.  Structurally distinct sigma-2 receptor ligands induce cell death in 
tumor cells, linking sigma-2 receptors to apoptotic pathways. Recently, we reported that sigma-2 
receptors can also stimulate glycolytic hallmarks; effects consistent with a pro-survival function 
and upregulation in cancer cells.  Both apoptotic and metabolically stimulative effects were 
observed with compounds related to the canonical sigma-2 antagonist, SN79.  Here we 
investigate a series of 6-substituted SN79 analogs in order to assess the structural determinants 
governing these divergent effects. Substitutions on the benzoxazolone ring of the core SN79 
structure resulted in high-affinity sigma-2 receptor ligands (K<sub>i</sub> = 0.56–17.9 nM), 
with replacement of the heterocyclic oxygen by –NMe (N-methylbenzimidazolones) generally 
decreasing sigma-1 affinity and a sulfur substitution (benzothiazolones) imparting high affinity 
at both subtypes, lowering subtype selectivity. Substitution at the 6-position with -
COCH<sub>3</sub>, –NO<sub>2</sub>, -NH<sub>2</sub>, or –F resulted in ligands that 
were not cytotoxic.  Five of these ligands induced an increase in metabolic activity, as measured 
by increased reduction of MTT in human SK-N-SH neuroblastoma cells, further supporting a 
role for sigma-2 receptors in metabolism.  Substitution with 6-isothiocyanate resulted in ligands 
that were sigma-2 selective and that irreversibly bound to the sigma-2 receptor, but not to sigma-
1. These ligands induced cell death upon both acute and continuous treatment 
(EC<sub>50</sub> = 7.6 - 32.8 &[mu]M), suggesting that irreversible receptor binding plays a 
role in cytotoxicity.  These ligands will be useful for further study of these divergent roles of 
sigma-2 receptors. 
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 The sigma-2 receptor is a 21.5 kDa protein, recently identified as the known protein 
TMEM97 (Hellewell and Bowen, 1990; Hellewell et al., 1994; Alon et al., 2017).  Due to its 
upregulation in tumors compared to healthy tissue, the sigma-2 receptor (sigma-2R/TMEM97) 
has been implicated in cancer cell proliferation as well as developed into a tool for tumor 
imaging (Vilner et al., 1995; Mach et al., 1997; Wheeler et al., 2000; Mach and Wheeler, 2009; 
Zeng et al., 2011; Shoghi et al., 2013). Additionally, a connection between sigma-2 receptors and 
Alzheimer’s disease has been described (Izzo et al., 2014a,b; Sahlholm et al., 2015; Yi et al., 
2017).  The sigma-2 receptor may also have some relationship to progesterone receptor 
membrane component 1 (PGRMC1), though the two proteins are not synonymous as initially 
proposed (Xu et al., 2011; Abate et al., 2015; Chu et al., 2015). They are both upregulated in 
cancer, both appear to be involved in regulation of cell viability, are largely co-localized in cells, 
and isolation of PGRMC1 was achieved using a sigma-2 selective probe.  Thus, it is imperative 
that the pharmacology of the sigma-2 receptor be further developed and described in order to 
understand the pathways, mechanisms, and functions associated with it. 
 Functional classification of sigma-2 receptors is not standardized, with different 
investigators preferring different criteria for characterization.  Generally, agonists of the sigma-2 
receptor are considered to induce programmed cell death.  Cleavage of Bid, caspase-3 activation, 
induction of an immediate rise in cytosolic calcium, and positive TUNEL staining have been 
proposed as markers of sigma-2 receptor agonist activity (Vilner and Bowen, 2000; Crawford 
and Bowen, 2002; Hazelwood and Bowen, 2006; Wang and Bowen, 2006; Zeng et al., 2014; 
Nicholson et al., 2015).  Recently, we described a novel function of sigma-2 receptors, where a 
sigma-2 receptor ligand, CM764, induced an increase in various markers of glycolytic cellular 
This article has not been copyedited and formatted. The final version may differ from this version.













metabolism as initially assessed by an increase in MTT reduction, without inducing changes in 
cell viability or cell proliferation (Nicholson et al., 2016).  This effect was blocked by various 
sigma-2 receptor antagonists.  In addition to the increase in MTT reduction, the effect comprised 
an increased level of NAD+/NADH and ATP, a marked decrease in basal ROS level, and an 
increase in HIF1α which may be connected to an observed increase in VEGF expression 
(Nicholson et al., 2016).  Thus sigma-2 receptors may have a dual role with respect to cellular 
survival and may activate different pathways depending on the ligand.  How this occurs is not 
clear.  Interestingly, some of the effects of CM764 are similar to those mediated by PGRMC1, 
which has previously been associated with the sigma-2 receptor, as mentioned above (Xu et al., 
2011; Abate et al., 2015; Chu et al., 2015).  Notably, PGRMC1 has been implicated in 
stimulation of VEGF gene expression (Neubauer et al., 2009).  PGRMC1 generally has pro-
proliferative, pro-survival, and anti-apoptotic effects in cells (Losel et al., 2008; Neubauer et al., 
2009; Ahmed et al., 2010; Peluso et al., 2010).  It is conceivable that PGRMC1 is involved in 
sigma-2/TMEM97 signaling in some way or that some sigma-2 ligands interact directly with 
PGRMC1.  However, more studies would be necessary to address this. 
A significant challenge for study of the sigma-2 receptors is the paucity of highly sigma-2 
selective ligands. There exist several sigma-1-selective ligands, but ligands with high selectivity 
for sigma-2 over sigma-1 are relatively scarce.  SN79 is a moderately selective sigma-2 receptor 
antagonist (Ki = 7 and 28 nM at sigma-2 and sigma-1, respectively) (Kaushal et al., 2011).  Here, 
we characterize a novel series of SN79 analogs with single-element variations at the 6-position 
of the benzoxazolone, N-methylbenzimidazolone, and benzothiazolone heterocyclic systems.  
The study sought to determine a structural foundation for sigma-2 receptor affinity and 
selectivity.  Furthermore, both cytotoxic effects and metabolic stimulative effects were induced 
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by compounds within the same SN79-related structural class in various cell lines.  CM572 
induced programmed cell death (Nicholson et al., 2015), while CM764 induced metabolic 
stimulation (Nicholson et al., 2016).  Thus we further explored structural determinants of these 
divergent effects within this class.  The study provides further evidence supporting a dual role of 
the sigma-2 receptor and provides a foundation from which to design targeted sigma-2 receptor 
ligands that are highly selective and result in inclusion into a predicted functional class. 
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Materials and Methods 
2.1 Compound Syntheses 
 The synthesis and characterization of compounds are described in the supplemental 
information to this manuscript (Supplemental Methods). 
 
2.2 Radioligand Binding Assays 
 Radioligand competition binding assays were performed as previously described 
(Nicholson et al., 2015). Briefly, 150 µg rat liver membrane protein was incubated for 120 
minutes at 25ºC in 20 mM HEPES, pH 7.4 with varying concentrations of each novel ligand and 
3 nM [3H](+)-pentazocine (PerkinElmer, Waltham, MA) for measuring sigma-1 receptors or 5 
nM [3H]DTG (PerkinElmer, Waltham, MA) to measure sigma-2 receptors in the presence of 100 
nM unlabeled (+)-pentazocine to mask sigma-1 receptors in a final volume of 0.5 mL. 
Haloperidol (10 µM) was used to determine nonspecific binding. After incubation, assays were 
terminated by dilution with 5 mL ice cold 10 mM Tris pH 7.4 and filtration through 0.5% 
polyethyleneimine-soaked fiberglass filters using a Brandel Cell Harvester (Brandel, 
Gaithersburg, MD) and two additional 5 mL washes in the same buffer. GraphPad Prism 6 
software (GraphPad Software, La Jolla, CA) was used to determine Ki values with [3H](+)-
pentazocine Kd=7.5 nM at sigma-1 receptors in rat liver homogenates and [3H]DTG Kd=17.9 nM 
at sigma-2 receptors in rat liver homogenates. 
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 For irreversible binding studies, 0.3 mg protein/mL membrane homogenate was treated 
with the indicated concentration of each isothiocyanate-substituted ligand individually for 60 
minutes in 20 mM HEPES pH 7.4 at 25ºC. This preparation was then diluted to 0.018 mg 
protein/mL using ice-cold 20 mM HEPES and centrifuged for 10 min at 37,000 x g. The pellet 
was resuspended to the original volume with ice-cold buffer and centrifuged again, and then 
resuspended again to the original volume. Non-covalently bound ligand was then allowed to 
dissociate during a 60 minute incubation at 25ºC prior to centrifugation of the preparation at 
37,000 x g for 10 minutes and resuspension of the pellet in 50 mM Tris, pH 8.0 to a 
concentration of 0.6 mg/mL. This homogenate was used directly in binding studies at a final 
protein concentration of 0.3 mg protein/ml in 0.5 mL total volume in incubation with [3H](+)-
pentazocine and [3H]DTG (with unlabeled (+)-pentazocine) to determine recovery of sigma-1 
and sigma-2 binding sites, respectively. Control membranes were treated in the same manner 
without exposure to ligand. This membrane preparation procedure was able to dissociate 500 nM 
SN79 from both sigma-1 and sigma-2 receptors, indicating successful removal of non-
irreversibly bound ligand. 
 
2.3 Cell Culture 
 Human SK-N-SH neuroblastoma cells (ATCC, Manassas, VA) were cultured in MEM 
(Gibco, Grand Island, NY) containing 10% fetal bovine serum, 10 mg/L human insulin, and 1X 
Pen-Strep (Gibco, Grand Island, NY) in a humidified atmosphere at 37 ºC and 5% CO2. Cells 
were passaged at 70% confluency. 
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2.4 Cell Viability and Metabolic Stimulation Assays  
 Cell viability was measured using MTT assays (Trevigen, Gaithersburg, MD). Cells were 
plated in 96-well plates at 15,000 cells/well and allowed to attach overnight. Cells were then 
treated with the indicated concentrations of ligand in a final volume of 100 µL for 24 hours. 
After this period, 10 µL of MTT Reagent was added to each well and allowed to be metabolized 
for 3 hours at 37 ºC, then 100 µL MTT Detergent Reagent was added and allowed to solubilize 
formazan crystals and cell membranes for 2 additional hours. Absorbance was then read at 570 
nm.  A decrease in absorbance was indicative of a loss of viable cells, and percent cytotoxicity 
was calculated using the percent loss in formazan formation in treated cells as compared to 
untreated cells by the following formula: 
% Cytotoxicity = 100 – [(O.D. treated cells – O.D. media blank / O.D. untreated control cells – 
O.D. media blank) x 100] 
EC50 values for dose-response curves were determined using GraphPad Prism 6 software 
(GraphPad Software, La Jolla, CA). 
 For acute treatments, cells were treated with ligand for 60 minutes and then washed twice 
with fresh ligand-free media to remove any non-irreversibly bound ligand. Fresh ligand-free 
media (100 µL) was then added to each well and allowed to incubate for 24 hours at 37 ºC prior 
to MTT assay as described above. 
Some compounds in this study were found to produce an increase in MTT reduction 
relative to control, as opposed to a decrease, in the 24 h period of incubation.  This is indicative 
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of a stimulation in cellular metabolism.  Metabolic stimulation was represented as percent 
change in MTT reduction and was calculated using the following formula: 
% Change in MTT Reduction = [100 x (O.D. treated cells – O.D. media blank) / (O.D. 
untreated control cells – O.D. media blank)] – 100 
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3.1 Binding affinity at sigma-1 and sigma-2 receptors 
SN79 was used as the lead compound in this study.  SN79 (Table 1) has a benzoxazolone 
heterocycle, where X=O.  Analogous benzothiazolones (X=S) and N-methylbenzimidazolones 
(X=NMe) were synthesized.  Within the three heterocyclic families, various substitutions at the 
6-position were examined, including compounds were R= acetyl (-COCH3), isothiocyanate (-
NCS), nitro (-NO2), and amine (-NH2).  All ligands were examined for their ability to bind 
sigma-1 and sigma-2 receptors using [3H](+)-pentazocine to measure sigma-1 receptors and 
[3H]DTG to measure sigma-2 receptors in the presence of unlabeled (+)-pentazocine to mask 
sigma-1 receptors as described in Materials and Methods.  Results are summarized in Table 1. 
 When ligands with the same R-group were compared, there existed a trend towards a loss 
of high-affinity binding at sigma-1 receptors for compounds with –NMe- X-group substitutions. 
This was most clearly exemplified with WA403 (R=NH2) (and to a lesser extent with NF7 
(R=COCH3)), where there is a striking rightward shift in the sigma-1 binding competition curves 
for the –NMe- substituted ligand when compared to the other ligands with R=NH2 and either 
X=O or X=S, as demonstrated in Figure 1.  When X=NMe, the sigma-1 affinity was decreased 
by at least 6.5-fold for R=COCH3 in the same comparisons. When R=NO2, the X=NMe 
substitution still demonstrated the lowest affinity binding as compared to other X-group 
substitutions, however the shift was less drastic. For WA404 (R=NCS) the –NMe- substituted 
ligand bound sigma-1 receptors with ~8 times lower affinity than the corresponding X=S 
substitution (WA435). For CM572 (R=NCS, X=O), a valid Ki value could not be determined at 
sigma-1 receptors due to solubility limits of the ligand. However, it is clear that CM572 (X=O, 
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R=NCS) is an outlier in this series due to its lack of significant sigma-1 receptor binding and 
therefore its extreme selectivity. 
 Comparing ligands with the same X-group substitution allowed for a comparison of the 
effects of R-group substitutions on sigma-1 receptor binding affinity. Ligands with R=NCS 
generally had a significantly decreased affinity for sigma-1 receptors as compared to any other 
R-group substitution. This is best demonstrated by CM572 (R=NCS, X=O), where the 
isothiocyanate substituted ligand has a decrease in sigma-1 receptor binding affinity of over 500-
fold when compared to any other R-group substitution, as shown in Figure 2. For X=S 
substitutions, there was at least a 3-fold loss of sigma-1 affinity for the isothiocyanate (WA435) 
substitution as compared to the other R-group substitutions. As mentioned above, sigma-1 
receptor binding affinity was not high for any ligand when X=NMe (Figure 1), and WA404 
(R=NCS, X=NMe) had a low affinity Ki value of 449 nM at the sigma-1 receptor, although this 
was not the lowest affinity of the X=NMe substituted ligands. 
It is not immediately clear why, within each heterocyclic system, the R=NCS analogs 
would demonstrate lower affinity for sigma-1 compared to the other substituents. They do not 
covalently bind to the sigma-1 receptor (see below), presumably due to the lack of a properly 
oriented receptor nucleophile in or near the binding site. However, this would not necessarily 
affect sigma-1 binding affinity. It is possible that there are steric issues affecting fit of the 
isothiocyanate group into the binding pocket. Another possibility is that these ligands may 
assume a "flipped" binding conformation in the sigma-1 binding pocket. Electronic effects may 
also come into play, since sigma-1 affinity of the isothiocyanates is affected by the nature of the -
X-moiety in the heterocycle. Further studies to determine ligand bound X-ray crystal structures 
would be needed to confirm these possibilities. 
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 The effect of X-group substitutions on receptor affinity was not limited to the sigma-1 
subtype. When sigma-2 affinities were compared, X=S substituted ligands had generally high 
sigma-2 affinity as compared to X=O and X=NMe substituted ligands.  Ligands with varying X 
group substitutions and either R=NCS (left panel) or R=NH2 (right panel) are shown in Figure 3 
for sigma-2 receptor binding.  WA435 (R=NCS, the X=S) showed at least a 7-fold increase in 
sigma-2 receptor affinity as compared to other X-group substitutions (left panel).  Similarly, 
when R=NH2, the sulfur X group substitution resulted in higher affinity ligands compared to 
X=O and X=NMe substitutions (right panel).  Similar results were also observed when 
R=COCH3.  Since X=S substitution resulted in ligands with sigma-2 receptor affinities that were 
between 2-4 nM, this indicates that the benzothiazolone heterocycle represents an optimal 
platform for further development of high affinity sigma-2 ligands.  Furthermore, the lower 
sigma-1 affinity of the R=NCS derivative resulted in WA435 having 28.5-fold selectivity for 
sigma-2 receptors. 
Across all three heterocycles, R=NO2 substitutions generally resulted in very high affinity 
sigma-2 ligands, with Ki values better than 8 nM.  Of particular note is CM458 (X=O, R=NO2) 
which exhibited subnanomolar affinity at sigma-2 receptors (Ki = 0.56 nM). 
 The variations in the X-position that resulted in drastic effects on binding affinity at both 
sigma-1 and, to a lesser extent, sigma-2 receptor binding affinity naturally also demonstrated an 
effect on subtype selectivity of the ligands. It should be noted that all ligands demonstrated at 
least slightly selective binding for the sigma-2 receptor over the sigma-1 receptor except for 
CM571 (X=O, R=NH2). Generally, having an oxygen in the X-position led to more highly 
sigma-2 selective ligands, while having a sulfur in this position generally decreased selectivity 
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(Table 1). However, this trend was less closely adhered to than trends in binding at each 
individual receptor. 
Overall the modifications yielded five new compounds that have higher sigma-2 receptor 
binding affinity than the parent compound, with CM458 exhibiting 12.3-fold higher affinity than 
SN79.  They also resulted in seven ligands that are significantly more selective for sigma-2 
relative to sigma-1, compared to SN79.  Notably, WA435, CM458, WA403, and CM572 were 
respectively, 28.5-, 39.6-, 167-, and >685-fold selective for sigma-2 over sigma-1.  This is a 
marked improvement over SN79 which was only 4-fold selective.  
 
3.2 Irreversible binding capability at sigma-1 and sigma-2 receptors 
The isothiocyanate moiety was added with the idea of imparting irreversible binding 
capability to the ligands through potential nucleophilic attack from an amine or thiol group 
appropriately positioned in the binding pocket of the sigma-2 receptor.  We have previously 
shown that CM572 (X=O, R=NCS) is able to irreversibly bind to the sigma-2 receptor 
(Nicholson et al. 2015). In the current study, we examined two additional R=NCS substituted 
ligands for their ability to irreversibly bind sigma-1 and sigma-2 receptors. Figure 4 shows 
results of ligand washout experiments.  Both WA404 (X=NMe, R=NCS) and WA435 (X=S, 
R=NCS) were able to irreversibly bind sigma-2 receptors, with WA435 (X=S, R=NCS) having a 
higher potency for irreversible binding (Figure 4). This trend correlates with sigma-2 receptor 
binding affinity differences, as the X=S substituted ligands have a higher affinity for sigma-2 
receptors than the X=NMe substituted ligands. Neither isothiocyanate potently irreversibly 
bound sigma-1 receptors, although WA404 (X=NMe, R=NCS) did show some ability to 
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irreversibly block sigma-1 receptor binding at high doses.  Interestingly, despite the relatively 
higher affinity of WA435 for sigma-1 receptors and saturation at the highest concentration 
examined (1,000 nM), the compound was completely washed out of the receptor, confirming 
lack of a suitable neighboring nucleophile in sigma-1 receptor.   
 
3.3 Effect of acute and continuous exposure to ligand on cell viability in SK-N-SH 
neuroblastoma 
 One generally accepted criterion for classification of a sigma-2 receptor ligand as an 
agonist is the ability to induce cell death. In order to classify the function of the ligands in this 
study, MTT cell viability assays were used to determine the efficacy and potency of the ability of 
each ligand to induce cell death in SK-N-SH neuroblastoma. The R-group substitution had the 
greatest effect on the ability of each ligand to induce cell death.  The only compounds in the 
series with the ability to potently decrease cell viability were those with R=NCS, regardless of 
X-group substitution.  Data for the most active compounds is depicted in Figure 5. The 
isothiocyanate substituted ligands all were able to induce a reduction in cell viability in the SK-
N-SH neuroblastoma with an EC50 below 35 µM, with CM572 (X=O, R=NCS) being the most 
potent with an EC50 of 7.6 µM, as previously reported (Nicholson et al., 2015).  Isothiocyanates 
with other X-group substitutions (X=NMe and X=S) demonstrated less potent EC50 values 
(WA404=30.4 ± 1.1 µM and WA435=32.8 ± 1.1 µM).  Some non-isothiocyanate ligands were 
also able to induce cell death, but were much less potent than the isothiocyanates.  WA413 (X=S, 
R=NO2) reached ~36% cytotoxicity at a dose of 50 µM after 24 h treatment. An EC50 value for 
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this ligand could not confidently be determined due to insolubility at high doses.  WA402 
(X=NMe, R=NO2) exhibited <50% cell death at a concentration of 100 µM.  
  The radioligand binding study demonstrated that the isothiocyanate substitution did 
impart the ability of the ligands to irreversibly bind sigma-2 receptors in each heterocycle class, 
while sigma-1 receptor irreversible binding was not generally observed (Figure 4).  The effect of 
this irreversible binding on cell viability was further tested by treating SK-N-SH neuroblastoma 
with an acute 60 minute pretreatment with the isothiocyanate ligands, followed by extensive 
washing and a 24 hour incubation in fresh ligand-free media. Cell viability was assessed after 
this period, and any induced cell death was attributed to ligand irreversibly bound and therefore 
continuously activating sigma-2 receptors throughout the 24 hour incubation without free ligand. 
Results are shown in Figure 6.  All isothiocyanate derivatives were found to continue to induce 
cell death after the acute 60 minute pretreatment, washing, and 24 hour incubation in media 
without free ligand. For both CM572 (X=O, R=NCS) and WA404 (X=NMe, R=NCS), the acute 
treatment reached comparable levels of cell death as the 24 hour incubation with ligand, with no 
statistically significant differences between the two exposure times (p=0.13 and p=0.056 for 
comparison of 24 hour incubation with ligand and 60 minute acute treatment for CM572 and 
WA404, respectively, Student’s t-test). Interestingly, for WA435 (X=S, R=NCS) the efficacy of 
the ligand increased when treated acutely as compared to the 24 hour continuous exposure 
(p=0.003 for comparison of the two conditions, Student’s t-test).  It should be noted here that in 
our previous study using siramesine, removing siramesine (which cannot bind irreversibly to 
sigma receptors) after a 60 min pretreatment of SK-N-SH neuroblastoma cells completely 
prevented induction of cell death (Nicholson et al. 2016).  This rules out the possibility that a 60 
This article has not been copyedited and formatted. The final version may differ from this version.













min acute exposure to sigma-2 agonist is enough time to commit to a cell death program, such 
that cell death would occur after subsequent removal of even a reversibly bound ligand. 
 When cell viability data from all the compounds is considered, the data clearly shows that 
in order for the compounds in this SN79-related series to be potently cytotoxic, the 
isothiocyanate group must be present.  This could indicate that irreversible binding to sigma-2 
receptors is a requirement for cytotoxicity.  However, another explanation for the efficacy of the 
isothiocyanate ligands is that the strong electron-withdrawing character of this moiety influences 
the receptor interaction such that the efficacy is altered.  In order to discriminate between the 
effect of irreversible binding and the effect of the strong electron withdrawing character of the 
isothiocyanate moiety on cell viability, an R-group substitution with fluorine was investigated to 
represent the strong electron withdrawing character of the isothiocyanate but without the 
capability to irreversibly bind to the sigma-2 receptor.  This ligand, WA379 (X=NMe, R=F), 
bound with high affinity and selectivity to sigma-2 receptors (Table 1; Ki=100.7 nM at sigma-1 
receptors and 6.1 nM at sigma-2 receptors).  When the effect of treatment with the fluorine 
substituted ligand on cell viability was examined, no significant cytotoxicity was induced (data 
not shown).  Instead, a metabolic stimulation effect was observed (see below).  These results 
demonstrate that the strong electron withdrawing character of the isothiocyanate group alone is 
not sufficient to induce significant levels of cell death, while irreversible binding was sufficient 
to induce cytotoxicity. 
     Another possible explanation for the observation that the isothiocyanate derivatives are the 
most potent cytotoxic ligands is that the effect is due to a non-specific off target effect of the 
isothiocyanate and that the sigma-2 receptor is playing no role.  The –NCS moiety could be 
attacked by a nucleophile on any protein which could result in general toxicity to the cell, 
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especially in the higher micromolar range.  We examined this by assessing the effect of 
phenylisothiocyanate (PhNCS) on sigma receptor binding and SK-N-SH cell viability.  PhNCS 
would not be expected to exhibit sigma receptor affinity, but should readily enter cells and 
potentially be attacked by protein nucleophiles.  Figure 7 (panel A) shows that PhNCS indeed 
had no appreciable effect on sigma-1 or sigma-2 receptor binding at concentration up to 100 µM.  
Figure 7 (panel B) shows the effect of PhNCS on cell viability in media with two concentrations 
of fetal bovine serum, 2% and the normal 10%.  High and low concentrations of FBS were used 
to examine possible serum effects on the –NCS group, though concentration of FBS was found 
to have no effect on activity of CM572 (X=O, R=NCS) in our previous study (Nicholson et al. 
2015).  There was no significant cytotoxic effect of PhNCS on SK-N-SH cells.  A dose of 10 µM 
induced no significant cytotoxic effect, and there was < 25% cytotoxicity at 100 µM PhNCS 
over a 24 h incubation period at either FBS concentration.  Taken together, the data show that 
specifically targeting the isothiocyanate to the sigma-2 receptor is necessary to affect both 
binding activity and cytotoxic efficacy of the isothiocyanate SN79 derivatives.  Thus, it appears 
that irreversible sigma-2 receptor binding activity imparted by the isothiocyanate moiety may 
play a key role in the cell death-inducing activity of these analogs. 
 
3.4 Effect of ligand treatment on metabolic reduction of MTT 
 We have recently described a novel, non-toxic, non-zero function for sigma-2 receptors 
using the SN79 derivative CM764 (Nicholson et al., 2016). Five of the ligands investigated in 
this series replicated this effect, inducing an increase in reduction of MTT upon 24 h treatment as 
compared to untreated cells. Results are shown in Figure 8. The five ligands (CM458, CM571, 
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NF7, WA504, and WA379) that promoted significantly increased MTT reduction in SK-N-SH 
neuroblastoma all had high sigma-2 receptor binding affinity, with receptor subtype selectivity 
varying widely.  These compounds have R-group substitutions representing all possibilities 
examined except R=NCS, which was shown to be toxic in all cases, as described above. 
Additionally, this subset of five ligands encompasses all three possible X-group substitutions 
examined. These data indicate that neither X-group nor R-group alone determine the ability to 
induce increased reduction of MTT.  
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 The goal of this study was to establish a relationship between ligand structure, binding 
affinity and selectivity, and functional efficacy of a series of novel SN79 derivatives at sigma-1 
and sigma-2 receptors. The parent compound, SN79 displays ~4-fold selectivity for the sigma-2 
receptor over sigma-1, and has been screened for off-target binding without any significant hits 
(Kaushal et al., 2011). SN79 is a sigma-2 receptor antagonist, and does not induce cell death 
even at high doses (Garcia, 2012). As one of the few sigma-2 selective ligands that has been 
thoroughly characterized, this was a natural starting point for development of additional sigma-2 
receptor selective ligands with which to study structural parameters affecting receptor affinity 
and ability to induce either cell death or a metabolically stimulative effect in SK-N-SH 
neuroblastoma cells.  We synthesized a series of ligands with single-moiety changes using the 
core structure of SN79 to examine these relationships.  
 Table 1 shows binding affinity of the analogs at sigma-1 and sigma-2 receptors. Affinity 
at sigma-1 receptors was significantly decreased for ligands with X=NMe substitutions, 
suggesting potential steric strain at this position in the binding pocket of the sigma-1 receptor 
(Figure 1). Sterically smaller X-group substitutions (X=O and X=S) did not result in a general 
decrease in sigma-1 receptor binding affinity, lending strength to this hypothesis. Another 
possibility is that the sigma-1 receptor binding pocket may have an ideally situated hydrogen 
bond donor that the X=O and, to a weaker extent, the X=S substitutions could participate in to 
promote higher affinity binding. However, this is a less likely cause as X=S substitutions had 
generally higher affinity binding, yet sulfur is a much weaker hydrogen bond acceptor than 
oxygen. Another factor that demonstrated a decrease in sigma-1 receptor binding affinity is the 
isothiocyanate R-group substitution. Derivatives with R=NCS generally had lower affinity for 
This article has not been copyedited and formatted. The final version may differ from this version.













the sigma-1 receptor compared to the other substitutions, which resulted in a trend of increased 
selectivity for the sigma-2 receptor. All ligands in this series except CM571 (X=O, R=NH2) 
demonstrated at least slight selectivity for the sigma-2 receptor, which was maintained from the 
parent compound SN79. 
 Sigma-2 receptor binding affinity was increased for ligands with R=NO2 substitutions 
(Figure 2) and independently for ligands with X=S substitutions (Figure 3). The X=S substitution 
also generally resulted in an increase in affinity at sigma-1 receptors (although to a lesser extent), 
which resulted in reduced sigma-2 receptor selectivity. However, compared to sigma-1 affinity, 
sigma-2 receptor affinity appears to be less dependent on interplay between X- and R-group 
substituents, with compounds generally having high affinity at sigma-2 receptors. These results 
are consistent with the ligand core structure, in which the X-position and R-position are 
conjugated. Therefore, resonance allows for changes in the X-group to affect electron density at 
the R-position, and vice versa. 
 Substitution of the R-group with an isothiocyanate allowed for the possibility of 
irreversible binding if there were an ideally positioned amine (lysine) or thiol (cysteine) group in 
the binding pocket of the receptor. This irreversible binding capability was confirmed by 
measuring recovered radioligand binding after pretreatment with isothiocyanate-substituted 
ligands followed by washout of any non-irreversibly bound ligand. All isothiocyanate substituted 
ligands were able to irreversibly bind sigma-2 receptors, while only WA404 (X=NMe, R=NCS) 
showed any ability to irreversibly bind sigma-1 receptors and not with high potency. This 
indicates that the isothiocyanate in the R-position may be ideally placed for covalent bond 
formation in the sigma-2 receptor binding pocket, but not in the sigma-1 receptor binding pocket. 
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     Interestingly, only R=NCS substituted ligands in this series were able to induce significantly 
potent levels of cell death in SK-N-SH neuroblastoma, indicating agonist activity (Figure 5). 
This ability to induce cell death appears to be a result of the capacity to irreversibly bind sigma-2 
receptors, rather than a result of the highly electron withdrawing group in the R-group position, 
as neither R=NO2 substituted ligands nor an R=F substituted ligand were able to induce 
significant cell death in comparable concentration range. These data indicate that irreversible 
binding is sufficient to induce cytotoxicity, while simply having a highly electron withdrawing 
group in the same position is not.  Furthermore, cytotoxicity of the isothiocyanate required 
specific targeting to the sigma-2 receptor, since phenyl isothiocyantate, which lacks sigma 
receptor affinity, had little effect on cell viability.  Interestingly, while irreversible binding may 
play some role with SN79 analogs, irreversible binding is clearly not required for sigma-2 
receptor-induced cell death in compounds from other structural classes, such as CB-64D, 
siramesine, and SV119, that lack an –NCS group and the ability to bind covalently. 
 We surmised that irreversible sigma-2 binding would impart long-lasting effects on 
sigma-2 receptor function.  When SK-N-SH cells were acutely treated with isothiocyanate 
substituted ligands for 60 minutes followed by extensive washing and 24 hour incubation in 
media without free ligand, the levels of cytotoxicity achieved were comparable to those after 24 
hour continuous incubation with ligand for both CM572 (X=O, R=NCS) and WA404 (X=NMe, 
R=NCS) (Figure 6). This indicates that the ability to irreversibly bind sigma-2 receptors also 
imparts the ability to continue to activate these receptors and induce cytotoxicity without free 
ligand present in the media. WA435 (X=S, R=NCS) was found to induce cell death more 
potently when acutely treated and then incubated in media without free ligand for 24 hours as 
compared to a 24 hour continuous exposure to ligand.  WA435 is the only isothiocyanate ligand 
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that retains significant affinity for the sigma-1 receptor, although it does not irreversibly bind the 
sigma-1 subtype. This may explain the increased potency in the acute treatment.  If WA435 is a 
sigma-1 agonist, the 24 hour continuous exposure would allow continuous occupancy of the 
sigma-1 receptor, activation of which is known to promote cell survival (Hayashi and Su, 2007; 
Wu and Bowen, 2008).  This could therefore compete with the cytotoxic effect of sigma-2 
receptor activation. In the acute treatment, all ligand would be washed out of sigma-1 receptors 
and this pro-survival pathway would no longer be activated.  Whether covalent attachment to the 
receptor via the 6-isothiocyanato moiety is key to cytotoxicity will require further study. 
 We have recently shown the ability of a novel SN79 derivative, CM764, to induce a non-
toxic, non-zero effect through the sigma-2 receptor, comprised in part by a stimulation of MTT 
reduction (Nicholson, et al. 2016).  In the current series, five of the thirteen SN79 derivatives 
shared this CM764-like phenotype with respect to stimulation of MTT reduction. While it is 
difficult to determine a very clear relationship between structure and ability to increase MTT 
reduction in SK-N-SH neuroblastoma cells, our data show some trends.  High sigma-2 receptor 
affinity was a common factor for all ligands with this function. Neither R-group alone nor X-
group alone could explain the relationship between ligand structure and the ability to induce 
increased MTT reduction, as compounds representing all X- substitutions and R- substitutions 
(with the exception of –NCS) caused MTT stimulation.  Furthermore, there are also “neutral” 
compounds.  For example, SN79 (X=O, R=COCH3) itself neither kills cells nor induces 
significant stimulation of metabolism at 30 µM (Nicholson et al., 2016).  In fact, 30 µM SN79 
was able to completely attenuate the metabolic stimulation induced by 10 µM CM764. This, 
along with complete blockade by a low, sub-cytotoxic dose (300 nM) of the highly sigma-2 
receptor-selective CM572, contributed to supporting evidence that the stimulatory effect is 
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mediated by sigma-2 receptors (Nicholson et al., 2016).  Also, the only difference between the 
neutral SN79 and metabolic stimulative CM458 and CM571 is NO2 or NH2 in the 6-position, 
respectively, vs. COCH3.  Thus, subtle changes in structure have marked effects on compound 
efficacy.  It seems probable that these phenotypes derive from a combinatorial effect. The X-
group and R-group are conjugated in the series investigated in this study, and therefore both 
positions could contribute to the development of this stimulative function. In addition, with 
CM764, X= O, R=COCH3 and there is an amine moiety in the fluorophenyl ring, indicating that 
modifications of the other ring system also affect the stimulatory efficacy.  Further studies on the 
combinatorial effects and electron density changes with additional X-group and R-group 
substitutions may help elucidate this relationship. 
     The results of this study show that sigma-2 receptor ligands in the SN79-related platform can 
be divided into two activity classes:  those that induce programmed cell death and those that 
stimulate MTT reduction (metabolic stimulation).  This is summarized in Figure 9.  A third class 
may be those compounds that are neutral and possibly antagonists.  We have postulated that the 
metabolic stimulation effect (as first characterized in detail with CM764; Nicholson et al., 2016) 
may be related to a survival role, consistent with the upregulation of sigma-2 receptors in cancer 
cells, and involved in the enhancement of tumor cell adaptation in hypoxic environment.  It is not 
yet clear how the sigma-2 receptor mediates both induction of apoptosis and this non-toxic effect 
on metabolism.  SN79 analogs will be helpful in resolving this issue. 
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Legends for Figures 
Figure 1. Effect of X-group substitutions on sigma-1 receptor binding affinity.  Affinity at 
sigma-1 receptors was determined by competition against [3H](+)-pentazocine as described in 
Materials and Methods.  Ki values for sigma-1 receptor binding of R=NH2 substituted ligands 
were determined to be 15.5 ± 2.4 nM, 2987.7 ± 506.9 nM, and 15.6 ± 2.8 nM for CM571 (X=O, 
R=NH2), WA403 (X=NMe, R=NH2), and WA416 (X=S, R=NH2) substitutions, respectively. 
This series dramatically demonstrates the general loss of sigma-1 receptor affinity for X=NMe 
substituted ligands compared to other X-group substitutions. Competition curves shown are an 
average of 3 independent experiments for CM571, 5 independent experiments for WA403, and 3 
independent experiments for WA416. All experiments were performed in duplicate. Ki values 
reported are an average of the individual Ki value from each independent experiment, ± S.D. 
 
Figure 2. Effect of R-group substitutions on sigma-1 receptor binding affinity.  Affinity at 
sigma-1 receptors was determined by competition against [3H](+)-pentazocine as described in 
Materials and Methods. Sigma-1 receptor binding affinity was significantly decreased when 
R=NCS for all X-group substitutions. This pattern is most clearly illustrated for X=O substituted 
ligands, with CM572 (X=O, R=NCS) showing at least a 350-fold loss in sigma-1 receptor 
binding affinity as compared to other R-group substitutions. Ki values for X=O substituted 
ligands at sigma-1 receptors were determined to be 28.03 ± 3.39* nM, >10,000 nM, 22.2 ± 5.3 
nM, and 15.5 ± 2.4 nM for SN79 (X=O, R=COCH3), CM572 (X=O, R=NCS), CM458 (X=O, 
R=NO2), and CM571 (X=O, R=NH2), respectively. An accurate Ki value for CM572 (X=O, 
R=NCS) at sigma-1 receptors could not be determined due to insolubility above 1 mM, however 
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~50% of [3H](+)-pentazocine binding sites remained with 10,000 nM CM572 present. 
Competition curves shown are an average of 4 independent experiments for SN79, 2 independent 
experiments for CM572, 3 independent experiments for CM458, and 3 independent experiments 
for CM571. All experiments were performed in duplicate. Ki values reported are an average of 
the individual Ki value from each independent experiment, ± S.D. (*Kaushal et al., 2011) 
 
Figure 3. Effect of X-group substitutions on sigma-2 receptor binding affinity.  Affinity at 
sigma-2 receptors was determined by competition against [3H]DTG as described in Materials and 
Methods.  Generally, X-group substitutions with sulfur resulted in ligands with very high sigma-
2 receptor binding affinity, ranging between 2-4 nM Ki values. This trend generally held true 
across R-group changes, and was most drastically demonstrated by the WA435 (X=S, R=NCS) 
and WA416 (X=S, R=NH2) comparisons depicted here.  For R=NCS (left panel), WA435 (X=S, 
R=NCS) showed at least a 7-fold higher binding affinity as compared to the other X-group 
substituted ligands. Similarly, for R=NH2 (right panel), WA416 (X=S, R=NH2) showed at least a 
4.5-fold higher binding affinity compared to the other X-group substituted ligands. Competition 
curves shown are an average of 4 independent experiments for CM572, 6 independent 
experiments for WA404, 3 independent experiments for WA435, 3 independent experiments for 
CM571, 5 independent experiments for WA403, and 3 independent experiments for WA416. All 
experiments were performed in duplicate. 
 
Figure 4. Irreversible binding of isothiocyanate-substituted ligands at sigma-1 and sigma-2 
receptors. Rat liver membrane homogenates were treated with isothiocyanate-substituted ligands 
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for 60 minutes prior to washing to remove any reversibly bound ligand as described in Materials 
and Methods. Recovery of sigma-1 and sigma-2 binding sites was then determined using 
[3H](+)-pentazocine for sigma-1 receptors and [3H]DTG for sigma-2 receptors, as described in 
Materials and Methods.  Data is presented as the percentage of total sigma receptors of each 
subtype recovered.  CM572 (X=O, R=NCS) (panel A) was previously shown to irreversibly bind 
sigma-2 receptors but not sigma-1 receptors (Nicholson et al. 2015). WA404 (X=NMe, R=NCS) 
(panel B) and WA435 (X=S, R=NCS) (panel C) also showed the ability to selectively and 
irreversibly bind sigma-2 receptors. WA404 (X=NMe, R=NCS) demonstrated some slight ability 
to irreversibly bind sigma-1 receptors, but only at high concentrations. Data shown is the average 
of at least two independent experiments for each condition, with each experiment performed in 
duplicate. 
 
Figure 5. Effect of isothiocyanate derivatives on cell viability of SK-N-SH neuroblastoma.  
SK-N-SH neuroblastoma cells were plated at 15,000 cells/well and allowed to attach overnight 
prior to dosing with indicated concentration of each ligand.  Cells were incubated with the 
indicated compounds for 24 hours, prior to determination of viable cells remaining using MTT 
assay, as described in Materials and Methods. Data are presented as % cytotoxicity.  All three 
isothiocyanate derivatives induced dose-dependent cell death.  EC50 values were 7.6 ± 1.7 µM*, 
32.76 ± 1.05 µM, and 30.35 ± 1.13 µM for CM572 (X=O, R=NCS), WA435 (X=S, R=NCS), 
and WA404 (X=NMe, R=NCS), respectively.  Dose-response curves shown are an average of 3 
independent experiments each ligand, with each experiment performed using 5 replicates per 
condition. EC50 values were determined from average cytotoxicity. (*Nicholson et al., 2015) 
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Figure 6. Comparison of acute and continuous exposure to isothiocyanate substituted 
ligands on cell viability of SK-N-SH neuroblastoma. Cells were plated at 15,000 cells/well 
and allowed to attach overnight prior to dosing with indicated concentration of each ligand.  
Cells were incubated with indicated ligand continuously for 24 hours (black bars) or cells were 
treated with ligand for 60 minutes followed by extensive washing with fresh media and 24 hour 
incubation in ligand-free media (white bars).  At the end of the 24 hour period, viable cells 
remaining were determined by MTT assay.  Treatment with all three isothiocyanate derivatives 
resulted in either comparable or greater levels of cell death in the acute exposure experiment as 
in the 24 hour continuous exposure (p=0.13, 0.056, and 0.003 for CM572, WA404, and WA435 
comparisons of the two exposure conditions, Student’s t-test). These data indicate that the 
isothiocyanate substituted ligands continue to induce cell death as a result of their capacity to 
irreversibly bind sigma-2 receptors even after free ligand is removed. Results are presented as 
the percentage of cells killed in response to each treatment compared to untreated control cells. 
Data is presented as an average of 3 independent experiments for each condition for each ligand, 
± S.D. All experiments were performed with 5 replicates per condition. 
 
Figure 7. Binding of phenyl isothiocyanate at sigma receptors and effect on viability of SK-
N-SH neuroblastoma.  A) Sigma-1 and sigma-2 receptor binding was determined by 
competition of phenyl isothiocyanate with [3H](+)-pentazocine or [3H]DTG in the presence of 
unlabeled (+)-pentazocine, respectively. No significant binding at sigma-1 or sigma-2 receptors 
was observed upon competition with phenyl isothiocyanate. Experiments were performed in 
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duplicate.  B) Cells were plated at 15,000 cells/well and allowed to attach overnight prior to 
treatment with the indicated concentrations of phenyl isothiocyanate for 24 h, followed by MTT 
assay. No significant cytotoxicity was observed in 2% serum conditions, and only very high 
concentrations of phenyl isothiocyanate reached significance in 10% serum conditions as 
compared to untreated cells (two-way ANOVA Dunnett’s multiple comparisons post-hoc test 
*p<0.05 compared to untreated cells) 
 
Figure 8. Ability of SN79 derivatives to increase reduction of MTT in SK-N-SH 
neuroblastoma. Cells were plated at 15,000 cells/well and allowed to attach overnight prior to 
treatment with indicated ligand and concentration for 24 h, followed by MTT assay. Five out of 
twelve SN79 derivatives in this series demonstrated the ability to induce a significant increase in 
the amount of MTT reduced as compared to untreated cells (two-way ANOVA overall p<0.0001. 
Dunnett’s multiple comparisons post-hoc test *p<0.05, ***p<0.001, ****p<0.0001 compared to 
untreated cells). All R-group substitutions were represented except R=NCS, which is consistent 
with the ability of R=NCS ligands to induce cell death. All X-group substitutions were also 
represented in this subset, and all ligands demonstrated high sigma-2 receptor binding affinity. 
Results are presented as the percent change in MTT reduction as compared to an untreated 
control, which was normalized to zero. Data are presented as an average ± S.D. of at least three 
independent experiments for each condition, with each experiment performed using five 
replicates per condition.  
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Figure 9.  Divergent effects of SN79 analogs. Diagram shows structural relationship of 
compounds examined in this study and the effects that are elicited.  SN79 is shown as the parent 
compound.  The heterocyclic X-atom was varied as O (benzoxazolone), N-methyl (N-
methylbenzimidazolone), and S (benzothiazolone).  The R-group in the 6-position was 
substituted with isothiocyanate, nitro, amine, methylketone, or fluorine.  Only compounds with 
R=NCS, regardless of heterocycle, were able to potently induce programmed cell death.  Several 
compounds with the other 6-position substituents were metabolic stimulators, regardless of 
heterocycle.  Other non-isothiocyanates, including SN79 itself, were neutral, producing neither 
programmed cell death nor metabolic stimulation at concentrations up to 30 µM.  The dotted line 
linking the groups indicates that both effects appear to be mediated by sigma-2R/TMEM97. 
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Binding affinities of SN79 derivatives at sigma-1 and sigma-2 receptors. 
 
   Sigma binding affinities (Ki ± SD) (nM)  
   [3H](+)-pentazocine [3H]DTG  
Ligand X R sigma-1 sigma-2 s1/s2 
SN79 O COCH3 28.0 ± 3.39* 6.89 ± 0.09* 4.06 
CM572 O NCS ≥10,000† 14.6 ± 7.0† >685 
CM458 O NO2 22.2 ± 5.3 0.56 ± 0.38 39.6 
CM571 O NH2 15.5 ± 2.4 21.7 ± 5.3 0.7 
NF7 NMe COCH3 183 ± 13.9 20.6 ± 2.4 8.9 
WA404 NMe NCS 449 ± 44.4 36.3 ± 7.8 12.4 
WA402 NMe NO2 20.3 ± 6.5 7.4 ± 3.0 2.7 
WA403 NMe NH2 2,988 ± 507 17.9 ± 8.0 167 
WA504 S COCH3 8.1 ± 2.3 2.5 ± 2.7 3.2 
WA435 S NCS 56.9 ± 10.2 2.0 ± 1.5 28.5 
WA413 S NO2 6.1 ± 1.0 3.2 ± 0.3 1.9 
WA416 S NH2 15.6 ± 2.8 3.9 ± 0.5 4.0 
 
WA379 NMe F 101 ± 10.3 6.1 ± 1.7 16.5 
 
Radioligand competition binding assays were performed using [3H](+)-pentazocine to measure 
sigma-1 receptor and [3H]DTG in the presence of unlabeled (+)-pentazocine to measure sigma-2 
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receptors as described in Experimental Section. Single-position changes to the core structure of 
SN79 resulted in drastic changes in affinity and selectivity at sigma-1 and sigma-2 receptors. 
Generally, changes in the X-position determined selectivity, with –S- substitutions resulting in 
reduced selectivity and –O- substitutions resulting in increased selectivity for the sigma-2 
receptor. R-group substitutions did not demonstrate a discernably consistent pattern across the 
ligand series. An accurate Ki value could not be determined for CM572 (X=O, R=NCS) at 
sigma-1 receptors due to insolubility above 1 mM, however ~50% of total sigma-1 receptors 
were bound by 10,000 nM CM572 at compared to total available sigma-1 receptor binding 
capacity as measured by [3H](+)-pentazocine alone. Results are presented as an average Ki 
values from at least three independent experiments for each ligand (except for CM572 at sigma-1 
receptors), ± S.D. All experiments were performed in duplicate. *(Kaushal et al., 2011) 
†(Nicholson et al., 2015) 
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